TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,169,963
|
1,887,712
|
1,382,787 |
| Earnings before taxes |
128,388
|
95,693
|
71,595 |
| Total assets |
873,049
|
726,799
|
650,336 |
| Current assets |
489,171
|
322,512
|
311,776 |
| Current liabilities |
470,188
|
382,829
|
370,062 |
| Equity capital |
281,870
|
182,564
|
95,743 |
| - share capital |
744
|
748
|
688 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.3%
|
25.1%
|
14.7% |
| Turnover per employee |
6,200
|
5,393
|
3,951 |
| Profit as a percentage of turnover |
5.9%
|
5.1%
|
5.2% |
| Return on assets (ROA) | |||
| Current ratio |
104.0%
|
84.2%
|
84.2% |
| Return on equity (ROE) |
45.5%
|
52.4%
|
74.8% |
| Change turnover |
291,923
|
383,046
|
-63,262 |
| Change turnover % |
16%
|
25%
|
-4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.